bioRxivNeurosciencePreprint
Significant enrichment of Herpesvirus interactors in GWAS data suggests causal inferences for the association between Epstein Barr virus and multiple sclerosis
Rosella MechelliiD, Renato UmetoniD, Sundararajan SrinivasaniD, Arianna FornasieroiD, Michela FerraldeschiiD, IMSGC and WTCCC2, Diego CentonzeiD, Cinthia FarinaiD, Marco SalvettiiD, Giovanni RistoriiD
Abstract
We exploited genetic information to assess the role of non-genetic factors in multifactorial diseases. To this aim we isolated candidate \"interactomes\" (i.e. groups of genes whose products are known to physically interact with environmental exposures and biological processes, plausibly relevant for disease pathogenesis) and analyzed nominal statistical evidence of association with genetic predisposition to multiple sclerosis (MS) and other inflammatory and non-inflammatory complex disorders. The interaction between genotype and Herpesviruses emerged as specific for MS, with Epstein Barr virus (EBV) showing higher levels of significance compared to Human Herpesvirus 8 (HHV8) and, more evidently, to cytomegalovirus (CMV). In accord with this result, when we classified the MS-associated genes contained in the interactomes into canonical pathways, the analysis converged towards biological functions of B cells, in particular the CD40 pathway. When we analyzed peripheral blood transcriptomes in persons with MS, we found a significant dysregulation of MS-associated genes belonging to the EBV interactome in primary progressive MS. This study indicates that the interaction between herpesviruses and predisposing genetic background is of causal significance in MS, and provides a mechanistic explanation for the long-recognized association between EBV and this condition.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association
Rosella Mechelli, Renato Umeton, … Giovanni Ristori·bioRxiv·Jun 6, 2021
- Genetic evidence that the latency III stage of Epstein-Barr Virus infection is a therapeutic target for Multiple Sclerosis
Ali Afrasiabi, Grant Peter Parnell, … David Richmond Booth·bioRxiv·Aug 13, 2018
- VirTrack: A Framework for Inferring Viral Influence on Disease-Associated Transcriptomes -- Clinical Type-Specific Epstein-Barr Virus Pathogenesis in Multiple Sclerosis
Anna Onisiforou·bioRxiv·Oct 5, 2025
- Enhanced EBNA2-dependent activity in EBV-transformed B cells from patients with multiple sclerosis
Marissa Granitto, Ellie Kim, … Matthew T. Weirauch·medRxiv·Mar 9, 2026
- VirTarget: Virus-Informed Pharmacogenomics Framework Identifies Immunotherapies That Mitigate Epstein-Barr Virus-Driven Dysregulation in Multiple Sclerosis
Bekir Altas, Polymnia Georgiou, … Anna Onisiforou·bioRxiv·Nov 3, 2025
- Epstein-Barr virus promotes T cell dysregulation in a humanized mouse model of multiple sclerosis
J. R. Allanach, N. M. Fettig, … M. S. Horwitz·bioRxiv·Feb 23, 2022